276 related articles for article (PubMed ID: 37935945)
1. Discovery of small molecule degraders for modulating cell cycle.
Wang L; Yang Z; Li G; Liu Y; Ai C; Rao Y
Front Med; 2023 Oct; 17(5):823-854. PubMed ID: 37935945
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule degraders of cyclin-dependent kinase protein: a review.
Yu B; Du Z; Zhang Y; Li Z; Bian J
Future Med Chem; 2022 Jan; 14(3):167-185. PubMed ID: 34939427
[TBL] [Abstract][Full Text] [Related]
3. Role of cyclinT/Cdk9 complex in basal and regulated transcription (review).
Napolitano G; Majello B; Lania L
Int J Oncol; 2002 Jul; 21(1):171-7. PubMed ID: 12063565
[TBL] [Abstract][Full Text] [Related]
4. Cyclin/Cdk complexes: their involvement in cell cycle progression and mitotic division.
John PC; Mews M; Moore R
Protoplasma; 2001; 216(3-4):119-42. PubMed ID: 11732181
[TBL] [Abstract][Full Text] [Related]
5. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase.
Rana S; Mallareddy JR; Singh S; Boghean L; Natarajan A
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771669
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions.
Klein MA
Adv Protein Chem Struct Biol; 2020; 121():115-141. PubMed ID: 32312419
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
[TBL] [Abstract][Full Text] [Related]
9. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
10. Less-well known functions of cyclin/CDK complexes.
Palmer N; Kaldis P
Semin Cell Dev Biol; 2020 Nov; 107():54-62. PubMed ID: 32386818
[TBL] [Abstract][Full Text] [Related]
11. CDKs and cyclins in transition(s).
Fisher RP
Curr Opin Genet Dev; 1997 Feb; 7(1):32-8. PubMed ID: 9024639
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in neuro-oncology: the cell cycle--a review.
Dirks PB; Rutka JT
Neurosurgery; 1997 May; 40(5):1000-13; discussion 1013-5. PubMed ID: 9149259
[TBL] [Abstract][Full Text] [Related]
13. The CDK inhibitor NtKIS1a is involved in plant development, endoreduplication and restores normal development of cyclin D3; 1-overexpressing plants.
Jasinski S; Riou-Khamlichi C; Roche O; Perennes C; Bergounioux C; Glab N
J Cell Sci; 2002 Mar; 115(Pt 5):973-82. PubMed ID: 11870216
[TBL] [Abstract][Full Text] [Related]
14. Molecules inducing specific cyclin-dependent kinase degradation and their possible use in cancer therapy.
Zheng M; Zhang XY; Chen W; Xia F; Yang H; Yuan K; Yang P
Future Med Chem; 2024 Feb; 16(4):369-388. PubMed ID: 38288571
[TBL] [Abstract][Full Text] [Related]
15. Development of selective mono or dual PROTAC degrader probe of CDK isoforms.
Zhou F; Chen L; Cao C; Yu J; Luo X; Zhou P; Zhao L; Du W; Cheng J; Xie Y; Chen Y
Eur J Med Chem; 2020 Feb; 187():111952. PubMed ID: 31846828
[TBL] [Abstract][Full Text] [Related]
16. The emerging roles of the CDK/cyclin complexes in antiviral innate immunity.
Zheng C; Tang YD
J Med Virol; 2022 Jun; 94(6):2384-2387. PubMed ID: 34964486
[TBL] [Abstract][Full Text] [Related]
17. Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitors.
Thomas KL; Bouguenina H; Miller DSJ; Sialana FJ; Hayhow TG; Choudhary JS; Rossanese OW; Bellenie BR
ACS Chem Biol; 2024 Jan; 19(1):173-184. PubMed ID: 38193430
[TBL] [Abstract][Full Text] [Related]
18. Cyclins and related kinases in cancer cells.
Malumbres M
J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinases in cancer: Role, regulation, and therapeutic targeting.
Gupta A; Dagar G; Chauhan R; Sadida HQ; Almarzooqi SK; Hashem S; Uddin S; Macha MA; Akil ASA; Pandita TK; Bhat AA; Singh M
Adv Protein Chem Struct Biol; 2023; 135():21-55. PubMed ID: 37061333
[TBL] [Abstract][Full Text] [Related]
20. CDK activity sensors: genetically encoded ratiometric biosensors for live analysis of the cell cycle.
Martinez MAQ; Matus DQ
Biochem Soc Trans; 2022 Jun; 50(3):1081-1090. PubMed ID: 35674434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
